CRIS FY 2020 Earnings — Curis, Inc. Revenue & Financial Results | Market Cap Arena

CRISCuris, Inc.

$14M

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$11M+8.3% YoY

Gross Profit

$10M95.1% margin

Operating Income

-$25M-229.8% margin

Net Income

-$30M-276.0% margin

EPS (Diluted)

$-12.29

Cash Flow

Operating Cash Flow

-$26M

Free Cash Flow

-$26M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$204M

Total Liabilities

$74M

Stockholders' Equity

$131M

Cash & Equivalents

$130M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$11M	$10M	+8.3%
Gross Profit	$10M	$10M	+8.4%
Operating Income	-$25M	-$24M	-2.2%
Net Income	-$30M	-$32M	+6.9%